Literature DB >> 25723724

Hyponatremia and poor cognitive outcome following pediatric brain tumor surgery.

Cydni N Williams1, Jay Riva-Cambrin, Angela P Presson, Susan L Bratton.   

Abstract

OBJECT: Pediatric intracranial neoplasms are common and cause substantial neurological morbidity. Postoperative hyponatremia is also common and may exacerbate neurological injury. The authors performed an exploratory analysis to evaluate an exposure-response relationship between hyponatremia severity and cognitive function at discharge.
METHODS: A retrospective cohort of patients 0-19 years old who underwent a first intracranial neoplasm surgery at a pediatric tertiary care hospital was reviewed. Outcome was assessed by Pediatric Cerebral Performance Category (PCPC) score of 1-6 at hospital discharge. Poor outcome was defined as PCPC score 3-6, corresponding to moderate or worse disability.
RESULTS: Of 319 total children, 80 (25%) had poor outcomes. One hundred thirty-seven children (43%) had serum sodium concentrations ≤ 131-135 mEq/L and 39 (12%) had serum sodium concentrations ≤ 130 mEq/L. Lower nadir sodium concentration and longer duration of hyponatremia were significantly associated with worsening PCPC score (p < 0.001). Rapid sodium decreases and more hyponatremic episodes were also significantly associated with worsening PCPC score (p < 0.001). After adjustment for patient factors, tumor characteristics, and measures of sodium disruption, multivariable analysis revealed noncortical tumor locations and lower nadir sodium concentration (adjusted odds ratio 0.86, 95% confidence interval 0.78-0.95) were important independent risk factors for poor cognitive outcome.
CONCLUSIONS: Neurocognitive disability and hyponatremia are common in children undergoing surgery for intracranial neoplasms. This study found a significant association between severity of hyponatremia and worsened cognitive outcome, with an apparent exposure-response relationship. These data support the need for careful postoperative monitoring of serum sodium. Further research is needed to determine if prevention and treatment of hyponatremia can improve outcomes in these children.

Entities:  

Keywords:  CI = confidence interval; ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; IQR = interquartile range; OR = odds ratio; PCPC = Pediatric Cerebral Performance Category; VIF = variance inflation factor; cognitive function; hyponatremia; intracranial neoplasm; oncology; serum sodium

Mesh:

Substances:

Year:  2015        PMID: 25723724     DOI: 10.3171/2014.10.PEDS14368

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  3 in total

Review 1.  Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Authors:  Nicholas S Phillips; Elizabeth S Duke; Hannah-Lise T Schofield; Nicole J Ullrich
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

2.  Pediatric Intracranial Tumors over a 5-Year Period in a Tertiary Care Center of North Kerala, India: A Retrospective Analysis.

Authors:  Aparna Govindan; Rajeev Mandaka Parambil; Jacob Paul Alapatt
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec

3.  AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats.

Authors:  Junyang Li; Meicen Liu; Jin Gao; Yu Jiang; Limin Wu; Yuen-Ki Cheong; Guogang Ren; Zhuo Yang
Journal:  Brain Behav Immun       Date:  2020-02-22       Impact factor: 7.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.